Riskpilot← Back to searchSign inGet full accessORION PHARMA AS
ASActiveOrg 967727970Sandakerveien 130, 0484 OsloActivities of agents involved in the wholesale of other particular products · NACE 4618Est. 199313 employeeswww.orionpharma.no
Revenue 2024
NOK 52,8M
+8% vs 2023
EBITDA margin
18.0%
+84% vs 2023
Equity ratio
22.1%
Financial strength
Net profit 2024
NOK 7,7M
+78% vs 2023
| Revenue | NOK 52,8M | +8% |
| EBITDA | NOK 9,5M | +84% |
| Net profit | NOK 7,7M | +78% |
| Total assets | NOK 22,6M | -13% |
| Equity | NOK 5M | +17% |
| Employees | 13 | — |
Legal name
ORION PHARMA AS
Org number
967727970
Legal form
Aksjeselskap
NACE code
4618 · Activities of agents involved in the wholesale of other particular products
Founded
12. oktober 1993
Share capital
—
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller daglig leder og et styremedlem i fellesskap.
Address
Sandakerveien 130, 0484 Oslo
Website
www.orionpharma.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 36 741 | 35 898 | 45 856 | 48 686 | 52 773 |
| Staff expenses | −21 526 | −22 633 | −22 307 | −23 261 | −22 759 |
| EBITDA | 1 634 | 1 866 | 9 121 | 5 176 | 9 498 |
| Depreciation & amort. | −44 | −44 | −44 | −44 | −44 |
| EBIT | 1 590 | 1 823 | 9 077 | 5 132 | 9 454 |
| Net financials | 20 | 4 | 90 | 440 | 452 |
| Profit before tax | 1 610 | 1 827 | 9 167 | 5 572 | 9 906 |
| Tax | 407 | 422 | 2 047 | 1 241 | 2 186 |
| Net profit | 1 203 | 1 405 | 7 119 | 4 331 | 7 720 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 15 262 | 14 563 | 22 963 | 26 063 | 22 554 |
| Equity | 5 209 | 4 815 | 9 934 | 4 265 | 4 984 |
| Long-term debt | 16 | 17 | 16 | 13 | 9 |
| Short-term debt | 10 037 | 9 731 | 13 014 | 21 786 | 17 561 |
| Total debt | 10 053 | 9 748 | 13 029 | 21 799 | 17 570 |
EBITDA margin
18.0%
This company
15.8%
Market median
+14% vs market
20202024
Equity ratio
22.1%
This company
38.2%
Market median
-42% vs market
20202024
Return on equity
154.9%
This company
18.4%
Market median
+742% vs market
20202024
Net profit margin
14.6%
This company
8.1%
Market median
+80% vs market
20202024
Asset turnover
2.34×
This company
1.12×
Market median
+109% vs market
20202024
Debt / equity
3.53×
This company
0.62×
Market median
-469% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
JO Chief Executive Officer | Chief Executive Officer | 2015 |
| Former (1) | ||
EB Chief Executive Officer | Chief Executive Officer | 2015 – 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2011 | |
| Board of Directors | 2025 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Board of Directors | 2011 – 2025 | |
| Board of Directors | 2011 – 2024 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Orion Coporation | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ORION PHARMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jesper Otto Qvist-Pedersen | Chief Executive Officer | 0 companies |
| Elling Berg | Chief Executive Officer | 0 companies |
| Olli Heikki Huotari | Board of Directors | 0 companies |
| Satu Maarit Ahomäki | Chairman | 0 companies |
| Jari Ilmari Karlson | Board of Directors | 0 companies |
| Mikko Tapani Kemppainen | Board of Directors | 0 companies |
| René Kristian Lindell | Board of Directors | 0 companies |